Role of erythropoietin in reducing allogeneic transfusions after joint arthroplasty

J Bone Joint Surg Am. 2003 Sep;85-A(9):1795-800

Erythropoietin reduces the risk of exposure to allogeneic blood transfusion in THA and TKA

Vox Sang. 2016 Oct;111(3):219-225

Reduced transfusion rate without increase in VTE rate with erythropoietin in orthopaedic surgery

Ther Clin Risk Manag. 2018 Jul 10;14:1191-1204. doi: 10.2147/TCRM.S159134

Preoperative human recombinant erythropoietin reduces allogenic blood transfusion

Int Orthop. 2012 Apr;36(4):703-9. Epub 2011 Oct 1.

Iron combined with recombinant human erythropoietin: reduces anemia following TKA surgery

Transfusion. 2011 Jan;51(1):118-24

AAOS 2016: Novel EPO dose protocol associated with decreased hospital cost after TKA

No significant mean changes in hand grip and vigor from baseline between use of EPO and PA

J Arthroplasty. 2007 Apr;22(3):325-33

TKA: Epoetin alfa leads to improved hematological parameters and lower risk of transfusion

J Arthroplasty. 2006 Aug;21(5):628-35

Autologous wound drains have no effect on transfusion rates following THA/TKA

Bone Joint J. 2014 Jun;96-B(6):765-71

Erythropoiesis-stimulating agents reduce allogeneic blood transfusion in TKA and THA

J Arthroplasty. 2013 Oct;28(9):1463-72

Cell salvage system may reduce need for allogeneic transfusions in spinal fusion surgery

Eur Spine J. 2015 Feb;24(2):270-5.

Antifibrinolytic agents reduce blood loss and transfusion requirements in spine surgery

PLoS One. 2013 Nov 22;8(11):e82063

Tranexamic acid is effective in reducing blood loss, while maintaining safety, in THA

Arch Orthop Trauma Surg. 2013 Jul;133(7):1017-27. doi: 10.1007/s00402-013-1761-2. Epub 2013 Apr 25

Tranexamic acid reduces blood loss and required transfusions due to spinal surgery

Eur Spine J. 2013 Sep;22(9):1950-7